జర్నల్ ఆఫ్ క్లినికల్ కేస్ రిపోర్ట్స్

Tricuspid Valve Replacement after Extensive Endocarditis Using Cormatrix^® Extracellular Matrix

Abstract

 Fernando Lucero, Manuel Quiroz*, Cristian Baeza and Miguel Oyonarte

Tricuspid valve replace in patients with active endocarditis can be a challenging decision in surgical options. In this experience, we replaced the tricuspid valve using a handmade single tube of CorMatrix Extracellular Matrix (ECM) (CorMatrix Cardiovascular Inc, Roswell, Ga). Its showed to be safe and useful in a young patient with extensive valve destruction and early follow-up showed symptomatic resolution and valve normal function.